E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy
In patients treated for prostate cancer (PCa) with radical prostatectomy (RP), determining the risk of extraprostatic extension (EPE) and nodal involvement (NI) remains crucial for planning nerve-sparing and extended lymphadenectomy. The study aimed to determine proteins that could serve as immunohi...
Main Authors: | Piotr Zapała, Łukasz Fus, Zbigniew Lewandowski, Karolina Garbas, Łukasz Zapała, Barbara Górnicka, Piotr Radziszewski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/23/5587 |
Similar Items
-
Antibody-mediated targeting of the transferrin receptor in cancer cells
by: Rosendo Luria-Pérez, et al.
Published: (2016-11-01) -
Identification and Characterization of Elevated Expression of Transferrin and Its Receptor TfR1 in Mouse Models of Depression
by: Xin Chang, et al.
Published: (2022-09-01) -
Low expression of transferrin receptor 2 predict poor prognosis in gastric cancer patients
by: Qian‐Fu Zhao, et al.
Published: (2020-12-01) -
Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells
by: Guan Zhen He, et al.
Published: (2021-03-01) -
The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study
by: Piotr Zapała, et al.
Published: (2022-08-01)